DMOG is widely used in biomedical research due to its ability to inhibit hypoxia-inducible factor (HIF) prolyl hydroxylase. This inhibition stabilizes HIF, mimicking hypoxic conditions, which is crucial for studying cellular responses to low oxygen levels. It is particularly valuable in cancer research, as it helps understand tumor adaptation to hypoxia and potential therapeutic targets. Additionally, DMOG is employed in studies related to angiogenesis, ischemia, and metabolic regulation, providing insights into diseases like cardiovascular disorders and diabetes. Its role in stem cell research is also notable, as it aids in exploring hypoxia's impact on cell differentiation and regeneration.